Home | Health | CHMP backs Novartis's Zykadia for first-line use in lung cancer

CHMP backs Novartis's Zykadia for first-line use in lung cancer

A sign marks a building on Novartis’ campus in Cambridge, Massachusetts, U.S., February 28, 2017. Picture taken February 28, 2017.

REUTERS/Brian Snyder

Click here to Read from the source

antalya oto kiralama Google
x

Check Also

Joshua Paul: Nanny Viktoria Tautz guilty of killing shaken baby

A nanny who shook a 10-month-old boy to death “in a fit of anger” has ...

Shares
sunexpress